This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) rose 5.99% to $2.83 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 2.13% to 4,210.24 and the Dow Jones Industrial Average rising 1.63% to 33,309.51. The stock's rise snapped a two-day losing streak. Ocugen Inc. closed $14.82 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) rose 3.36% to $1.54, Ocular Therapeutix Inc. (OCUL) rose 18.33% to $5.81, and Kodiak Sciences Inc. (KOD) rose 14.47% to $12.50. Trading volume (5.9 M) remained 249,890 below its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2022.
(END) Dow Jones Newswires
August 10, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.